In-hospital mortality in HIV-infected patients: 10 years after the implementation of universal access to HAART in Mexico

To establish the characteristics and causes of death of HIV patients who die while hospitalized. We included HIV+ patients who died during hospitalization, in three hospitals in Mexico City between 2010 and 2013. Sociodemographic and clinical data were collected as well as causes of death. We identi...

Full description

Saved in:
Bibliographic Details
Published in:Salud pública de México 2015, Vol.57 Suppl 2, p.s163-s170
Main Authors: Martín-Onraet, Alexandra, Piñeirua-Menéndez, Alicia, Perales-Martínez, Diana, Ortega-Pérez, Raúl, Barrera-García, Alejandro, Sierra-Madero, Juan, Volkow-Fernández, Patricia
Format: Article
Language:Spanish
Subjects:
Adolescent
Adult
Aged
AIDS Serodiagnosis
AIDS-Related Opportunistic Infections - mortality
Antiretroviral Therapy, Highly Active
Cause of Death
CD4 Lymphocyte Count
Delayed Diagnosis
Female
Health Services Accessibility
Health Services Needs and Demand
HIV Infections - diagnosis
HIV Infections - drug therapy
HIV Infections - mortality
Hospital Mortality
Hospitalization - statistics & numerical data
Hospitals, Urban - statistics & numerical data
Humans
Inpatients - statistics & numerical data
Male
Mexico - epidemiology
Middle Aged
Mortality, Premature
Retrospective Studies
Socioeconomic Factors
Tertiary Care Centers - statistics & numerical data
Young Adult
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To establish the characteristics and causes of death of HIV patients who die while hospitalized. We included HIV+ patients who died during hospitalization, in three hospitals in Mexico City between 2010 and 2013. Sociodemographic and clinical data were collected as well as causes of death. We identified preventable deaths (defined as deaths that occurred in patients with less than six months of HAART, or without HAART, with less than 350 CD4 at diagnosis and/or opportunistic events as the cause of hospitalization). 128 deaths were analyzed. The median of CD4 count was 47 cells/mm³; 18% of the patients ignored their HIV status at the time of hospitalization, 51% had less than six months of HAART, 40.5% had never received HAART before. The main causes of death were AIDS defining events, with 65.6%. We identified 70 preventable deaths (57%). Despite universal access to HAART, HIV patients in Mexico are still dying of AIDS defining illnesses, an indicator of late diagnosis. It is urgent to implement HIV testing programs to allow earlier diagnosis and make HAART benefit accessible to all.
ISSN:1606-7916